Robert Fischer

Physics and Astronomy · Physical Sciences

28h-index3.2kcitations190works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Fiber Laser Technologies(57), Ovarian function and disorders(32), Reproductive Biology and Fertility(30), Nonlinear Photonic Systems(29), Laser-Matter Interactions and Applications(25)

Publications190 total

Can artificial intelligence models provide reliable medical counselling to fertility patients?
Reproductive BioMedicine Online·2025· 1 citedOpen Access
Introduction: luteinizing hormone for life’s journey
Reproductive Biology and Endocrinology·2025Open Access
Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria
Reproductive Biology and Endocrinology·2024· 3 citedOpen Access
Expert opinion on refined and extended key performance indicators for individualized ovarian stimulation for assisted reproductive technology
Fertility and Sterility·2024· 6 citedOpen Access
Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus
Frontiers in Reproductive Health·2024· 1 citedOpen Access
PSIV-15 Effects of dietary supplementation of carbohydrase on growth performance and health status of growing-finishing pigs
Journal of Animal Science·2024Open Access
Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 years
Reproductive BioMedicine Online·2023· 8 citedOpen Access
The Fischer Concept Protocol - Its Impact on Embryo Quality
Journal of IVF-Worldwide·2023Open Access
Withdrawal notice to: ‘Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: A German database study’ [YBEOG 89C (2023) 102350]
Best Practice & Research Clinical Obstetrics & Gynaecology·2023Open Access
WITHDRAWN: Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: A German database study
Best Practice & Research Clinical Obstetrics & Gynaecology·2023· 2 citedOpen Access
The Fischer protocol for assisted reproductive technology treatment: Real-world data experience comparing elective single versus double embryo transfer with or without comprehensive chromosome screening
Best Practice & Research Clinical Obstetrics & Gynaecology·2023· 3 cited
Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database Study
Gynecologic and Obstetric Investigation·2023Open Access
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry
Best Practice & Research Clinical Obstetrics & Gynaecology·2022· 7 citedOpen Access
Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus
Frontiers in Endocrinology·2022· 43 citedOpen Access
Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
Frontiers in Endocrinology·2021Open Access
Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
Reproductive Biology and Endocrinology·2021· 20 citedOpen Access
Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
Frontiers in Endocrinology·2021· 46 citedOpen Access
Commentary: A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator
Frontiers in Endocrinology·2020· 3 citedOpen Access
COST-EFFECTIVENESS ANALYSIS OF THE ORIGINATOR RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (R-HFSH) AND URINARY HIGHLY PURIFIED MENOPAUSAL GONADOTROPIN (HMG) BASED ON DATA FROM A LARGE GERMAN REGISTRY
Fertility and Sterility·2020
The Instability of Monolayer-Thick PbSe on VSe<sub>2</sub>
Chemistry of Materials·2020· 8 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Dragomir N. Neshev(16), Wiesław Królikowski(13), Yuri S. Kivshar(12), Carlo Alviggi(7), Sandro C. Esteves(7), Andrey A. Sukhorukov(7), Claus Yding Andersen(5), Alessandro Conforti(5), Sesh Kamal Sunkara(5), Peter Humaidan(5), K. Bühler(5), V. Baukloh(5), Nikolaos P. Polyzos(4), Solomon M. Saltiel(4), Daniela Galliano(3), Filippo Maria Ubaldi(3), Matheus Roque(3), Denis Träger(3), Cornelia Denz(3), O. Naether(3)